Table 1.
Study characteristics and complication outcomes
| Reference | Year | Evidence level | Technique | No. of repairs | Overall complications | Mesh infection | Surgical site infection | Obstruction | Other complications | Mortality | Follow-up months |
| Safadi | 2004 | 4 | KH | 9 | 3 | 0 | 0 | 0 | 3 | 0 | 24 |
| LeBlanc | 2005 | 4 | KH/SB | 12 | 4 | 0 | 0 | 1 | 3 | 1 | 20 |
| Berger | 2007 | 4 | SB | 41 | 3 | 0 | 1 | 1 | 1 | 0 | 241 |
| Mancini | 2007 | 4 | SB | 25 | 5 | 1 | 1 | 0 | 3 | 1 | 191 |
| McLemore | 2007 | 4 | KH/SB | 19 | 11 | 0 | 2 | 1 | 8 | 0 | 20 |
| Muysoms | 2008 | 4 | KH/SB | 24 | 2 | 0 | 0 | 0 | 2 | 0 | 22 |
| Berger | 2008 | 4 | Sandwich | 47 | 4 | 0 | 0 | 0 | 4 | 0 | 20 |
| Hansson | 2008 | 4 | KH | 55 | 6 | 2 | 0 | 0 | 4 | 0 | 361 |
| Craft | 2008 | 4 | KH/SB | 21 | 8 | 2 | 1 | 1 | 4 | 0 | 14 |
| Pastor | 2009 | 4 | KH/SB | 12 | 4 | 0 | 2 | 0 | 2 | 0 | 14 |
| Jani | 2010 | 4 | KH | 9 | 2 | 0 | 0 | 0 | 2 | 0 | 13 |
| Wara | 2011 | 4 | KH | 72 | 21 | 0 | 4 | 0 | 17 | 2 | 361 |
| Asif | 2012 | 4 | KH/SB | 33 | 13 | 0 | 4 | 1 | 8 | 0 | 12 |
| Mizrahi | 2012 | 4 | KH | 29 | 6 | 0 | 1 | 1 | 4 | 1 | 28 |
| Hansson | 2013 | 4 | SB | 61 | 12 | 1 | 1 | 0 | 9 | 1 | 26 |
| Weighted pooled % (95%CI) | 24.9% (17.9%-32.7%) | 1.7% (0.7%-3.1%) | 3.8% (2.3%-5.7%) | 1.7%(0.7%-3.0%) | 16.6%(11.9%-22.1%) | 1.8%(0.8%-3.2%) | |||||
1
Months in median instead of mean.